Quality pharmacy services and key performance indicators in Polish NICUs: a Delphi approach
- 233 Downloads
Background Currently, there is no literature describing what a quality level of practice entails in Polish neonatal intensive care units (NICUs), nor are there any means of currently measuring the quality of pharmaceutical care provided to NICU patients. Objective To identify a set of essential pharmacist roles and pharmacy-relevant key performance indicators (KPI’s) suitable for Polish neonatal intensive units (NICUs). Setting Polish hospital pharmacies and NICUs. Method Using a modified Delphi technique, potential KPI’s structured along Donabedian’s domains as well as pharmacy services were presented to an expert panel of stakeholders. Two online, consecutive Delphi rounds, were completed by panellists between August and September 2017. Main outcome measure To identify the minimum level of pharmacy services that should be consistently provided to NICU patients. Results A total of 16 panellists contributed to the expert panel. Overall, consensus of 75% was reached for 23 indicators and for 28 roles. When considering pharmacy services for the NICU, the experts were found to highly value traditional pharmacy roles, such as dispensing and extemporaneous compounding, however, they were still eager for roles in the other domains, such as educational and clinical services, to be listed as essential for NICU practice. Panellists were found to positively value the list of indicators presented, and excluded only 9 out of the total list. Conclusion There is a need for future research to establish a minimum standard of practice for Polish pharmacists to encourage the progression and standardisation of hospital pharmacy services to meet the level of practice seen in NICUs worldwide.
KeywordsDelphi technique Key performance indicators Neonatal Intensive Care Unit Pharmaceutical care Poland Quality measurement
The authors would like to express their sincere gratitude to all of the experts in Poland who participated in this research.
Conflicts of interest
The authors declare no conflicts of interest.
- 1.Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Cotter S, Barber N, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Health Syst Pharm. 1994;51(21):2676–84.Google Scholar
- 6.Łasocha P, Merks P, Olszewska A. Farmacja szpitalna i kliniczna w Wielkiej Brytanii (Hospital and Clinical Pharmacy in the United Kingdom). Farmacja Polska. 2013;69(9):527–30.Google Scholar
- 8.Piecuch A, Kozłowska-Wojciechowska M, Jaszewska E, Makarewicz-Wujec M. Farmaceuta kliniczny—odpowiedź na zmieniające się potrzeby społeczne (The Clinical Pharmacist—response to societal needs). Farm Pol. 2014;70(7):395–9.Google Scholar
- 9.Urbańczyk K. Czym właściwie jest Farmacja kliniczna? [What is clinical pharmacy?] Opieka Farmaceutyczna. 2017. http://opieka.farm/doniesienia/czym-wlasciwie-jest-farmacja-kliniczna/. Accessed 28 Oct 2017.
- 10.da Silva NMM. The impact of pharmacist participation in a multidisciplinary team on an oncology ward compared with a ward clinical pharmacy service. Eur J Hosp Pharm Sci Pract. 2012;19(2):259–60.Google Scholar
- 14.Dice J, Burckart G, Woo J, Helms R. Standardized versus pharmacist-monitored individualized parenteral nutrition in low-birth-weight infants. Am J Health Syst Pharm. 1981;38(10):1487–9.Google Scholar
- 15.Dunkley M. Neonatal intensive care–an Australian survey of the pharmacist’s role. Aust J Hosp Pharm. 1991;21:104–8.Google Scholar
- 20.Banks M, Board N, Curtis I, Davis E, Dunbar N, Jorm C. Developing a safety and quality framework for Australia. Darlinghurst: Australian Commission on Safety and Quality in Health Care; 2017.Google Scholar
- 21.European Directorate for the Quality of Medicines and HealthCare (EDQM). Pharmaceutical Care—policies and practices for a safer, more responsible and cost-effective health system. Strasbourg: Directorate for the Quality of Medicines and HealthCare of the Council of Europe, 2012.Google Scholar
- 25.Krzyżaniak N, Pawłowska I, Bajorek B. The role of the clinical pharmacist in the NICU: a cross-sectional survey of Australian and Polish pharmacy practice. Eur J Hosp Pharm. 2018:ejhpharm-2017-001432.Google Scholar
- 26.Fernandes O, Gorman SK, Slavik RS, Semchuk WM, Shalansky S, Bussieres JF, et al. Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach. Ann Pharmacother. 2015;49(6):656–69. https://doi.org/10.1177/1060028015577445.CrossRefPubMedGoogle Scholar
- 28.Christie CA, Barela E. The Delphi technique as a method for increasing inclusion in the evaluation process. Can J Program Eval. 2005;20(1):105–22.Google Scholar
- 29.Giannarou L, Zervas E. Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manag. 2014;9(2):66–82.Google Scholar
- 32.World Health Organization. Health Systems—Equity. 2017. http://www.who.int/healthsystems/topics/equity/en/. Accessed 02 Oct 2017.
- 33.Smoliński D. Farmacja szpitalna wychodzi z jaskini. RynekAptek. 2016. http://www.rynekaptek.pl/wywiad/farmacja-szpitalna-wychodzi-z-jaskini,16169_2.html. Accessed 02 Oct 2017.
- 35.Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy service. Geneva: World Health Organization, 2011 Contract No.: 961.Google Scholar
- 37.Department of Health and Human Services, Defining Levels of Care for Victorian Newborn Services, Melbourne; Victorian Government; 2015. Available from: www.health.vic.gov.au/maternitycare. Accessed 20 Nov 2017.
- 38.NICE. Specialist neonatal care quality standard. skilled and multidisciplinary staff. Manchester: NICE; 2010.Google Scholar
- 39.BAPM. Service standards for hospitals providing neonatal care. Pharmacy. London: BAPM; 2010.Google Scholar
- 40.Roughead L, Semple S, Rosenfeld E. Literature review: medication safety in Australia. Sydney: Australian Commission on Safety and Quality in Health Care 2013.Google Scholar
- 41.Medication Safety in the Neonatal Intensive Care Unit, Position Statement#3060 National Association of Neonatal Nurses, Chicago. 2014. http://nann.org/uploads/About/PositionPDFS/1.4.7_Medication Safety in the NICU.pdf. Accessed 15 Feb 2016.
- 42.Mikeal RL, Brown TR, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Health Syst Pharm. 1975;32(6):567–74.Google Scholar
- 43.WHO. Making pregnancy safer; assessment tool for the quality of hospital care for mothers and newborn babies. Advanced newborn care (for intensive care units). Copenhagen: WHO; 2009.Google Scholar
- 44.Clinical Pharmacist Intensive Care (PCICU, PICU, ED and NICU)—Pharmacy. Sidra Medical and Research Center. 2015. http://www.bayt.com/en/job/clinical-pharmacist-intensive-care-pcicu-picu-ed-and-nicu-pharmacy-in-qatar-50043520/. Accessed 04 Mar 2015.
- 47.Position Description: NICU Clinical Pharmacist Specialist. University of Kentucky Hospital 2009. http://www.hosp.uky.edu/pharmacy/departpolicy/PH14-45.pdf. 04 Mar 2007.
- 48.Cousins D KN, Walser S,. Pharmaceutical care: policies and practices for a safer, more responsible and cost effective health system. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe, 2012.Google Scholar